What does the evidence say about Chlorella Metabolic Health Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Chlorella Metabolic Health Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Conversely, catalase (WMD = 22.06 U/g.Hb; 95% CI: 3.19 to 40.93) increased significantly. [Mardani H (2026); evidence level 1] - While the evidence for BMI was rated as low, the certainty of evidence for most other outcomes was very low according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE). [Mardani H (2026); evidence level 1] - Our findings underscore the potential of Chlorella supplementation to support metabolic health in general population; however, given the overall very low certainty of evidence based on the GRADE assessment, these results should be interpreted cautiously. [Mardani H (2026); evidence level 1] - This systematic review and meta-analysis aimed to evaluate the potential benefits of Chlorella supplementation in the general population, with a focus on its impact across a broad spectrum of health-related biomarkers and clinical parameters. [Mardani H (2026); evidence level 1] - Plant-derived bioactive peptides have garnered widespread interest for their functions in managing obesity and associated metabolic disorders. [Lin L (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.